250 related articles for article (PubMed ID: 27618912)
1. Pathway-specific inhibition of primaquine metabolism by chloroquine/quinine.
Fasinu PS; Tekwani BL; Avula B; Chaurasiya ND; Nanayakkara NP; Wang YH; Khan IA; Walker LA
Malar J; 2016 Sep; 15(1):466. PubMed ID: 27618912
[TBL] [Abstract][Full Text] [Related]
2. Differential kinetic profiles and metabolism of primaquine enantiomers by human hepatocytes.
Fasinu PS; Avula B; Tekwani BL; Nanayakkara NP; Wang YH; Bandara Herath HM; McChesney JD; Reichard GA; Marcsisin SR; Elsohly MA; Khan SI; Khan IA; Walker LA
Malar J; 2016 Apr; 15():224. PubMed ID: 27093859
[TBL] [Abstract][Full Text] [Related]
3. Enantioselective metabolism of primaquine by human CYP2D6.
Fasinu PS; Tekwani BL; Nanayakkara NP; Avula B; Herath HM; Wang YH; Adelli VR; Elsohly MA; Khan SI; Khan IA; Pybus BS; Marcsisin SR; Reichard GA; McChesney JD; Walker LA
Malar J; 2014 Dec; 13():507. PubMed ID: 25518709
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of primaquine in normal human volunteers: investigation of phase I and phase II metabolites from plasma and urine using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry.
Avula B; Tekwani BL; Chaurasiya ND; Fasinu P; Dhammika Nanayakkara NP; Bhandara Herath HMT; Wang YH; Bae JY; Khan SI; Elsohly MA; McChesney JD; Zimmerman PA; Khan IA; Walker LA
Malar J; 2018 Aug; 17(1):294. PubMed ID: 30103751
[TBL] [Abstract][Full Text] [Related]
5. An LC-MS based study of the metabolic profile of primaquine, an 8-aminoquinoline antiparasitic drug, with an in vitro primary human hepatocyte culture model.
Jin X; Pybus BS; Marcsisin R; Logan T; Luong TL; Sousa J; Matlock N; Collazo V; Asher C; Carroll D; Olmeda R; Walker LA; Kozar MP; Melendez V
Eur J Drug Metab Pharmacokinet; 2014 Jun; 39(2):139-46. PubMed ID: 23797843
[TBL] [Abstract][Full Text] [Related]
6. Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial.
St Jean PL; Xue Z; Carter N; Koh GC; Duparc S; Taylor M; Beaumont C; Llanos-Cuentas A; Rueangweerayut R; Krudsood S; Green JA; Rubio JP
Malar J; 2016 Feb; 15():97. PubMed ID: 26888075
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine.
Daher A; Aljayyoussi G; Pereira D; Lacerda MVG; Alexandre MAA; Nascimento CT; Alves JC; da Fonseca LB; da Silva DMD; Pinto DP; Rodrigues DF; Silvino ACR; de Sousa TN; de Brito CFA; Ter Kuile FO; Lalloo DG
Malar J; 2019 Sep; 18(1):325. PubMed ID: 31547827
[TBL] [Abstract][Full Text] [Related]
8. The metabolism of primaquine to its active metabolite is dependent on CYP 2D6.
Pybus BS; Marcsisin SR; Jin X; Deye G; Sousa JC; Li Q; Caridha D; Zeng Q; Reichard GA; Ockenhouse C; Bennett J; Walker LA; Ohrt C; Melendez V
Malar J; 2013 Jun; 12():212. PubMed ID: 23782898
[TBL] [Abstract][Full Text] [Related]
9. The conversion of primaquine into primaquine-aldehyde, primaquine-alcohol, and carboxyprimaquine, a major plasma metabolite.
Frischer H; Mellovitz RL; Ahmad T; Nora MV
J Lab Clin Med; 1991 Jun; 117(6):468-76. PubMed ID: 2045714
[TBL] [Abstract][Full Text] [Related]
10. Pre-clinical evaluation of CYP 2D6 dependent drug-drug interactions between primaquine and SSRI/SNRI antidepressants.
Jin X; Potter B; Luong TL; Nelson J; Vuong C; Potter C; Xie L; Zhang J; Zhang P; Sousa J; Li Q; Pybus BS; Kreishman-Deitrick M; Hickman M; Smith PL; Paris R; Reichard G; Marcsisin SR
Malar J; 2016 May; 15(1):280. PubMed ID: 27188854
[TBL] [Abstract][Full Text] [Related]
11. Enantioselective pharmacokinetics of primaquine in healthy human volunteers.
Tekwani BL; Avula B; Sahu R; Chaurasiya ND; Khan SI; Jain S; Fasinu PS; Herath HM; Stanford D; Nanayakkara NP; McChesney JD; Yates TW; ElSohly MA; Khan IA; Walker LA
Drug Metab Dispos; 2015 Apr; 43(4):571-7. PubMed ID: 25637634
[TBL] [Abstract][Full Text] [Related]
12. Profiling primaquine metabolites in primary human hepatocytes using UHPLC-QTOF-MS with 13C stable isotope labeling.
Avula B; Tekwani BL; Chaurasiya ND; Nanayakkara NP; Wang YH; Khan SI; Adelli VR; Sahu R; Elsohly MA; McChesney JD; Khan IA; Walker LA
J Mass Spectrom; 2013 Feb; 48(2):276-85. PubMed ID: 23378100
[TBL] [Abstract][Full Text] [Related]
13. Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population.
Spring MD; Sousa JC; Li Q; Darko CA; Morrison MN; Marcsisin SR; Mills KT; Potter BM; Paolino KM; Twomey PS; Moon JE; Tosh DM; Cicatelli SB; Froude JW; Pybus BS; Oliver TG; McCarthy WF; Waters NC; Smith PL; Reichard GA; Bennett JW
J Infect Dis; 2019 Oct; 220(11):1761-1770. PubMed ID: 31549155
[TBL] [Abstract][Full Text] [Related]
14. Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: Current state of the art.
Marcsisin SR; Reichard G; Pybus BS
Pharmacol Ther; 2016 May; 161():1-10. PubMed ID: 27016470
[TBL] [Abstract][Full Text] [Related]
15. Antimalarials inhibit human erythrocyte membrane acetylcholinesterase.
Katewa SD; Katyare SS
Drug Chem Toxicol; 2005; 28(4):467-82. PubMed ID: 16298876
[TBL] [Abstract][Full Text] [Related]
16. CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine.
Pybus BS; Sousa JC; Jin X; Ferguson JA; Christian RE; Barnhart R; Vuong C; Sciotti RJ; Reichard GA; Kozar MP; Walker LA; Ohrt C; Melendez V
Malar J; 2012 Aug; 11():259. PubMed ID: 22856549
[TBL] [Abstract][Full Text] [Related]
17. Comparative single dose pharmacokinetics and metabolism of racemic primaquine and its enantiomers in human volunteers.
Khan W; Wang YH; Chaurasiya ND; Nanayakkara ND; Herath HB; Harrison KA; Dale G; Stanford DA; Dahl EP; McChesney JD; Gul W; ElSohly MA; Khan SI; Fasinu PS; Khan IA; Tekwani BL; Walker LA
Drug Metab Pharmacokinet; 2022 Aug; 45():100463. PubMed ID: 35709685
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of (+)-primaquine and (-)-primaquine enantiomers in rhesus macaques (Macaca mulatta).
Saunders D; Vanachayangkul P; Imerbsin R; Khemawoot P; Siripokasupkul R; Tekwani BL; Sampath A; Nanayakkara NP; Ohrt C; Lanteri C; Gettyacamin M; Teja-Isavadharm P; Walker L
Antimicrob Agents Chemother; 2014 Dec; 58(12):7283-91. PubMed ID: 25267666
[TBL] [Abstract][Full Text] [Related]
19. Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses.
Silvino AC; Costa GL; Araújo FC; Ascher DB; Pires DE; Fontes CJ; Carvalho LH; Brito CF; Sousa TN
PLoS One; 2016; 11(7):e0160172. PubMed ID: 27467145
[TBL] [Abstract][Full Text] [Related]
20. Primaquine and Chloroquine Fumardiamides as Promising Antiplasmodial Agents.
Beus M; Fontinha D; Held J; Rajić Z; Uzelac L; Kralj M; Prudêncio M; Zorc B
Molecules; 2019 Aug; 24(15):. PubMed ID: 31374989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
